Literature DB >> 16713605

Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature.

Gopalakrishnapillai Anilkumar1, Sonali P Barwe, Jason J Christiansen, Sigrid A Rajasekaran, Donald B Kohn, Ayyappan K Rajasekaran.   

Abstract

Prostate-specific membrane antigen (PSMA) is a transmembrane protein with a highly restricted profile of expression. Expression is primarily limited to secretory cells of the prostatic epithelium, with elevated levels observed in prostate cancer. As an integral membrane protein correlated with prostate cancer, PSMA offers a potentially valuable target for immunotherapy. PSMA is also detected in the neovasculature of a variety of solid tumors but not in the endothelial cells of preexisting blood vessels. Although the significance of PSMA expression in these cells remains elusive, this pattern of expression implies that PSMA may perform a functional role in angiogenesis and may offer a therapeutic target for the treatment of a broad spectrum of solid tumors. In this study, we have expressed PSMA in human microvascular endothelial cells and demonstrate that PSMA binds to caveolin-1 and undergoes internalization via a caveolae-dependent mechanism. The association between PSMA and caveolae in endothelial cells may provide important insight into PSMA function and ways to best exploit this protein for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713605     DOI: 10.1016/j.mvr.2006.03.004

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  12 in total

1.  A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.

Authors:  Andrew X Zhang; Ryan P Murelli; Cyril Barinka; Julien Michel; Alexandra Cocleaza; William L Jorgensen; Jacek Lubkowski; David A Spiegel
Journal:  J Am Chem Soc       Date:  2010-09-15       Impact factor: 15.419

2.  Janus model of the Na,K-ATPase beta-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization.

Authors:  Sonali P Barwe; Sanguk Kim; Sigrid A Rajasekaran; James U Bowie; Ayyappan K Rajasekaran
Journal:  J Mol Biol       Date:  2006-10-31       Impact factor: 5.469

Review 3.  Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

Authors:  C Bařinka; C Rojas; B Slusher; M Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 4.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

5.  alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.

Authors:  Landon J Inge; Sigrid A Rajasekaran; Daniel Wolle; Sonali P Barwe; Sergey Ryazantsev; Charles M Ewing; William B Isaacs; Ayyappan K Rajasekaran
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

6.  Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer.

Authors:  Ryan P Murelli; Andrew X Zhang; Julien Michel; William L Jorgensen; David A Spiegel
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

7.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Authors:  Colm Morrissey; Lawrence D True; Martine P Roudier; Ilsa M Coleman; Sarah Hawley; Peter S Nelson; Roger Coleman; Ya-Chun Wang; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Journal:  Clin Exp Metastasis       Date:  2007-10-31       Impact factor: 5.150

8.  Quantitative [Fe]MRI determination of the dynamics of PSMA-targeted SPIONs discriminates among prostate tumor xenografts based on their PSMA expression.

Authors:  Laurel O Sillerud
Journal:  J Magn Reson Imaging       Date:  2018-01-13       Impact factor: 4.813

9.  Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors.

Authors:  Patrícia M R Pereira; Komal Mandleywala; Ashwin Ragupathi; Jason S Lewis
Journal:  Clin Cancer Res       Date:  2020-09-30       Impact factor: 12.531

Review 10.  More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.

Authors:  Anniina Hyväkkä; Verneri Virtanen; Jukka Kemppainen; Tove J Grönroos; Heikki Minn; Maria Sundvall
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.